Tabernanthe iboga

Tabernanthe iboga

Tabernanthe iboga, or even for a short Iboga, Eboga, Eboka, or Obona called ( Ex.: Tabernanthe bocca, Tabernanthe pubescens, Tabernanthe tenuiflora ), a plant belonging to the family of Hundsgiftgewächse is ( Apocynaceae ).

Description

Tabernanthe iboga is a shrub that reaches the stature heights of 1 to 2 meters. The small leaves are shiny and lanceolate. The small flowers are white and pink. It forms large olive, orange fruit.

Dissemination

Widespread is Tabernanthe iboga mainly in Gabon and Congo. Native is the iboga shrub in the undergrowth of the tropical forests of Africa. It is grown in many areas of West Africa.

Ingredients

The root of the iboga, especially the inner layer of the root bark, contains psychoactive indole alkaloids, in particular the Ibogaine (12 -methoxy- ibogamine ). High-quality root bark can contain up to 6% ibogaine. In Germany Tabernanthe iboga ibogaine and falls within the definition of § 2 para 1 of the AMG, as soon as it is intended for use on humans or animals.

Use

The iboga root is consumed orally, tastes extremely bitter and is chewed in minced or ground state and swallowed with plenty of water.

Just as with the extracted bound ibogaine hydrochloride smaller doses are stimulating and aphrodisiac, while larger doses induce visions, that is lively waking dreams with my eyes closed. Unlike the pure ibogaine, however, the acute effect of iboga lasts longer (6-12 instead of 4-8 hours) and is subjectively perceived as less severe. The nausea and frequent vomiting at high doses, however, is even more pronounced.

The plant is now used mainly in the Bwiti cult among the Fang and Mitsogo in Gabon and adjacent areas of neighboring countries as ritual drug, be carried out with the healing and initiation ceremonies.

According to Howard Lotslof, one of the first and perhaps most significant to date, researchers in the field of medical use of Iboga, in 1990, the first anti-HCV ( hepatitis C ) Effects of iboga reported. Furthermore, it was recorded by the treatment with Iboga also an improvement in liver function tests. These results were presented by him during a scientific forum on Iboga in Warsaw in 2007.